2020-2027 Analysis and Review Bio Pharma Buffer Market

Bio Pharma Buffer Market

Bio Pharma Buffer Market By Type (Acetates, Phosphates, Organic and Others), By End Users (Biopharmaceutical Industry, Academia & Research Institutes and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020 – 2027

06-04-2020 REP-HC-5061 40 Tables 123 pages Format

The bio pharma buffer market was valued at USD626.0Mn by 2019. Rising prevalence of infectious disease worldwide and increasing research and development activities pertaining to novel drug development and vaccines production together drive the bio pharma buffer market. Strategic collaboration between pharmaceutical agents and academic research institutes to promote breakthrough research and technology to serve public health and welfare will further accentuate the bio pharma buffer market growth.

 Bio Pharma Buffer Market

The biochemical process occurring is impaired due to change in the free hydrogen ion concentration and thus it becomes necessary to stabilize the ionic concentrations of in vitro by the addition of some suitable buffer solution to the biochemical process without altering the rate of a chemical reaction and entire functionality of the process under investigation. Buffers basically comprises of acid and base conjugates, its quality is determined by its ability to resist change of the pH and ionic concentration of biochemical processes. Henderson-Hasselbalch equation is critical in determining the pH of the buffer solutions such as acetates, phosphates, carbonates, organic buffers, etc.

The major segments related to the bio pharma buffer market are:

By Type (2017–2027; US$ Mn)

Acetates

Phosphates

Organic

Others

By End Users (2017–2027; US$ Mn)

Biopharmaceutical Industry

Academia & Research Institutes

Others

Geography Segment(2017–2027; US$ Mn)

North America

United States
Canada

Europe

United Kingdom
Germany
Russia
France
Italy
Spain
Ukraine
Rest of Europe

Asia Pacific

China
Japan
Rest of Asia Pacific

Latin America (LATAM)

Brazil
Mexico
Rest of Latin America

Middle East and Africa (MEA)

GCC
Rest of MEA 

Justification for study?

  • The intention of the study is to give a comprehensive outlook of the global bio pharma buffer market
  • The overall segmentation of the Bio Pharma Buffer market, by type, end-users and geography is minutely studied. Phosphates and biopharmaceutical industry are dominating the type and end-user segments respectively
  • Increasing demand for vaccines as a prophylactic and therapeutic agent to enhance innate immunity to counter and fight against infectious disease
  • The constant rise in the drug development activities on account of the rising prevalence of non-communicable disease further accentuates the market growth

Report gist?

  • The study of the global bio pharma buffer market includes qualitative analysis of factors such as drivers, restraints, and opportunities
  • The report covers qualitative and quantitative analysis of the overall market segmented on the basis of type and end users and categorization of the same at geography level
  • This research report presents the analysis of each segment from 2017 to 2027 in which 2019 is considered as the base year. Compounded annual growth rate is calculated for the respective segments from 2020 to 2027
  • The study includes the profiles of major market players with a significant global and regional presence along with top company positioning 

Significant customers?

  • This study is suitable for industry participants and stakeholders in the biopharmaceutical companies engaged in manufacturing and marketing of bio pharma buffers to life science industries on account of increasing drug development activities to curb the intensity of non-communicable disease
  • The report will benefit researchers engaged in the development of novel vaccines to treat infectious diseases
  • Managers with financial institutions looking to publish recent and forecasted statistics pertaining to bio pharma buffer market
  • Financial institutions venture capitalist, analysts, investors, government organizations, policymakers, regulatory authorities, researchers, looking for insights into the market to determine future strategies 

Segment Analysis

Phosphate buffers are the most widely used bio pharma buffer in the life science industry and academic research institutes. The chief attributes responsible for its immense popularity among researchers is its pH, osmolarity, and ionic concentration matching with the human body. It is used as the diluent, rinse containers containing cells, reference spectrum to measure protein adsorption on ellipsometry. Organic buffers are anticipated to register rampant market growth on account of increasing demand for novel drug development such as vaccines, immunotherapy, biologics, etc.

The biopharmaceutical industry is currently leading the end-users segment for bio pharma buffer market. The looming threat of infectious disease-related to RNA viruses such as ebola, COVID-19, swine flu, etc. increases the demand for development of vaccines and novel drugs to curb the spread and mortality rate associate with the viral infections. Academia and research institutes across the globe are anticipated to register sturdy market growth on large monetary funds invested by government healthcare agencies and pharmaceutical giants to promote breakthrough research and technology to be utilized to support the health and wellness of mankind.

North America is dominating the geography segment for bio pharma buffer market. The major factors responsible for its positive market growth are a significant increase in the research and development activities for the treatment of communicable and non-communicable diseases in the region. The presence of the life sciences industry and world renounced academic research institutes increases the demand for bio pharma buffer market. Europe is behind in the 2nd position in the regional market for bio pharma buffer market. The constant rise in the development of novel vaccines and immunotherapy together drives the biopharma buffer market growth in the Western Europe region. Asia Pacific is anticipated to register comfortable market growth during the forecast period on account of developing healthcare infrastructure and flourishing drug formulation and development market.

Select License Type

$4,600
$6,600
$9,500

Safe and Secure SSL Encrypted

Have a Question?

We will help you find what you are looking for.

Call 1-518-730-1560

Contact sales

How can we help you?

Get in touch with us or find an office closest to you.